Xenon Pharmaceuticals Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-07
Interim MD&A - English.pdf
Results 2026-05-07
Interim financial statements/report – English.pdf
Results 2026-05-07
Xenon Reports Q1 2026 Financial Results and Provides Business Update
News release - English.pdf
Results 2026-04-23
Annual report - English.pdf
Results 2026-04-19
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
News release - English.pdf
News 2026-04-07
Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
News release - English.pdf
Transactions 2026-03-19 Financing
Xenon Pharmaceuticals Inc. Announces Closing of US$747.5 Million Offering
Material change report - English.pdf
News 2026-03-12
Other.pdf
Transactions 2026-03-12 Financing
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
News release - English.pdf
Transactions 2026-03-11 Financing
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
News release - English.pdf
News 2026-03-09
Other.pdf
Transactions 2026-03-09 Financing
Xenon Pharmaceuticals Announces Proposed Public Offering
News release - English.pdf
Results 2026-03-09
Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)
News release - English.pdf
Results 2026-03-09
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
News release - English.pdf
News 2026-02-27
Other.pdf
News 2026-02-27
Offering material - English.pdf
News 2026-02-27
Cover letter.pdf
Results 2026-02-27 Financials
Annual report on form 10-K - English.pdf
Results 2026-02-26
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
News release - English.pdf
Results 2026-02-26 Financials
Annual report - English.pdf
Results 2026-02-26 Financials
Annual MD&A - English.pdf
Results 2026-02-26 Financials
Audited annual financial statements – English.pdf
Results 2026-02-26
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
News release - English.pdf
News 2026-01-12
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference
News release - English.pdf
Ownership 2026-01-06
Mortimer, Ian Charles sold +$1.8M
Insider trading – 2026-01-06
1 insider · −$1.8M net
Ownership 2025-12-10
Mortimer, Ian Charles sold +$1.1M
Insider trading – 2025-12-10
1 insider · −$1.1M net
Results 2025-12-05
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025
News release - English.pdf
Ownership 2025-12-04
Mortimer, Ian Charles sold +$4k
Insider trading – 2025-12-04
1 insider · −$4k net
News 2025-12-01
Other.pdf
News 2025-12-01
Other.pdf
News 2025-11-25
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
News release - English.pdf
News 2025-11-06
News release - English.pdf
Results 2025-11-04 Financials
Interim MD&A - English.pdf
Results 2025-11-04 Financials
Interim financial statements/report – English.pdf
News 2025-11-03
News release - English.pdf
News 2025-10-27
News release - English.pdf
News 2025-10-18
Other.pdf
News 2025-10-18
Other.pdf
News 2025-10-16
News release - English.pdf
News 2025-10-07
News release - English.pdf
Ownership 2025-10-02
Mortimer, Ian Charles sold +$1.0M
Insider trading – 2025-10-02
1 insider · −$1.0M net
News 2025-09-25
News release - English.pdf
News 2025-08-29
News release - English.pdf
Results 2025-08-12 Financials
Interim MD&A - English.pdf
Results 2025-08-12 Financials
Interim financial statements/report – English.pdf
News 2025-08-11
News release - English.pdf
News 2025-08-04
News release - English.pdf
News 2025-08-01
News release - English.pdf
News 2025-07-04
Other.pdf
News 2025-06-27
News release - English.pdf
News 2025-06-26
News release - English.pdf
News 2025-06-24
News release - English.pdf
Ownership 2025-06-10
Gannon, Steven sold +$91
Insider trading – 2025-06-10
1 insider · −$91 net
News 2025-06-05
Other.pdf
News 2025-06-03
News release - English.pdf
Ownership 2025-01-28
Mortimer, Ian Charles sold +$2.2M
Insider trading – 2025-01-28
1 insider · −$2.2M net
Ownership 2024-12-18
Patou, Gary sold +$201k
Insider trading – 2024-12-18
1 insider · −$201k net